The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma.
about
Tumor stroma as targets for cancer therapyuPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.The fourth mammalian molybdenum enzyme mARC: current state of research.Targeting tumor cell motility to prevent metastasis.New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesThe urokinase plasminogen activator system in metastatic papillary thyroid carcinoma: a potential therapeutic targetPhase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancerClinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.The mammalian molybdenum enzymes of mARC.Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
P2860
Q27015980-3CFF7DC5-E9E3-4714-9E9E-A8FE07550B2AQ30249137-BA026212-07B6-4D89-9D6F-F25AF9A9906FQ34028677-30507B7C-A037-48E4-8EC9-AFEF4B6AF34FQ35095152-152B7FA8-B010-42B7-94A2-9FAAB7A33FDDQ35752611-90CE08D8-290B-4111-AB3F-08EBE23EEFA3Q36158388-E85AC28E-DB54-4AE2-9BB5-F5644C134682Q36663677-BF50A09B-F2E9-47BC-89FF-6AE883F51627Q37809871-02ED0247-9487-453D-85AD-52A1FB8B92C6Q38271482-891548C6-F790-446F-AE86-91E42226143CQ54960825-9393B0B5-F96D-49F2-8D1B-192AB59482F6
P2860
The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
The Oral Serine Protease Inhib ...... anced Head and Neck Carcinoma.
@ast
The Oral Serine Protease Inhib ...... anced Head and Neck Carcinoma.
@en
The Oral Serine Protease Inhib ...... anced Head and Neck Carcinoma.
@nl
type
label
The Oral Serine Protease Inhib ...... anced Head and Neck Carcinoma.
@ast
The Oral Serine Protease Inhib ...... anced Head and Neck Carcinoma.
@en
The Oral Serine Protease Inhib ...... anced Head and Neck Carcinoma.
@nl
prefLabel
The Oral Serine Protease Inhib ...... anced Head and Neck Carcinoma.
@ast
The Oral Serine Protease Inhib ...... anced Head and Neck Carcinoma.
@en
The Oral Serine Protease Inhib ...... anced Head and Neck Carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
The Oral Serine Protease Inhib ...... vanced Head and Neck Carcinoma
@en
P2093
Annette Rempel
Barbara Wollenberg
Carola Mala
Carsten Brocks
Hendrik Graefe
Jens E Meyer
Markus Bürgle
Natalie Thäns
Stephan Lang
P2860
P356
10.1159/000151736
P577
2008-10-16T00:00:00Z